Activation of the apoptotic pathway during prolonged prometaphase blocks daughter cell proliferation by Uetake, Yumi & Sluder, Greenfield
University of Massachusetts Medical School 
eScholarship@UMMS 
Radiology Publications and Presentations Radiology 
2018-11-01 
Activation of the apoptotic pathway during prolonged 
prometaphase blocks daughter cell proliferation 
Yumi Uetake 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/radiology_pubs 
 Part of the Cell Biology Commons, Cells Commons, Cellular and Molecular Physiology Commons, and 
the Enzymes and Coenzymes Commons 
Repository Citation 
Uetake Y, Sluder G. (2018). Activation of the apoptotic pathway during prolonged prometaphase blocks 
daughter cell proliferation. Radiology Publications and Presentations. https://doi.org/10.1091/
mbc.E18-01-0026. Retrieved from https://escholarship.umassmed.edu/radiology_pubs/427 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Radiology Publications 
and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
2632 | Y. Uetake and G. Sluder Molecular Biology of the Cell
MBoC | ARTICLE
Activation of the apoptotic pathway during 
prolonged prometaphase blocks daughter cell 
proliferation
ABSTRACT When untransformed human cells spend >1.5 h in prometaphase under standard 
culture conditions, all daughters arrest in G1 despite normal division of their mothers. We 
investigate what happens during prolonged prometaphase that leads to daughter cell arrest 
in the absence of DNA damage. We find that progressive loss of anti-apoptotic MCL-1 activ-
ity and oxidative stress act in concert to partially activate the apoptosis pathway, resulting in 
the delayed death of some daughters and senescence for the rest. At physiological oxygen 
levels, longer prometaphase durations are needed for all daughters to arrest. Partial activa-
tion of apoptosis during prolonged prometaphase leads to persistent caspase activity, which 
activates the kinase cascade mediating the post–mitotic activation of p38. This in turn acti-
vates p53, and the consequent expression of p21stops the cell cycle. This mechanism can 
prevent cells suffering intractable mitotic defects, which modestly prolong mitosis but allow 
its completion without DNA damage, from producing future cell generations that are suscep-
tible to the evolution of a transformed phenotype.
INTRODUCTION
The mitotic checkpoint maintains genomic integrity by blocking the 
metaphase–anaphase transition until all sister chromatids attach to 
opposite spindle poles (reviewed in Musacchio and Salmon [2007] 
and Lara-Gonzalez et al. [2012]). However, some problems in spin-
dle assembly or mitotic progression eventually allow checkpoint 
satisfaction and could result in a completed but defective mitosis. 
For example, in response to low concentrations of microtubule tar-
geting agents the checkpoint becomes satisfied after many hours 
even though the spindle is short and/or multipolar (Brito et al., 2008; 
Yang et al., 2009). For cells held in G2 and then released into mito-
sis, prolonging prometaphase with the Eg5 inhibitor monastrol can 
lead to centrosome fragmentation and mother–daughter centriole 
separation (Karki et al., 2017). Reduced spindle size can compro-
mise cleavage completion, and spindle multipolarity can lead to 
unequal chromosome distribution. In real life, environmental toxins, 
radiation, or chemotherapeutic agents could produce spindle de-
fects that result in completed but inaccurate mitoses. Also, environ-
mental stresses that prolong prometaphase without diminishing 
spindle assembly/function can lead to cohesion fatigue that com-
promises genomic stability (reviewed in Gorbsky [2013]). Whether or 
not the cell has a way to protect against such mitotic defects that 
evade the mitotic and DNA damage checkpoints has not been clear.
Once the mitotic checkpoint is satisfied and the cell completes 
mitosis, it would be logical for the daughter cells to proliferate re-
gardless of prometaphase duration. However, when untransformed 
cells are continuously treated with microtubule targeting agents, 
they remain in prometaphase for up to 40 h and after slipping into 
interphase arrest in G1 (Cross et al., 1995; Minn et al., 1996; Lanni 
and Jacks, 1998; Rieder and Maiato, 2004; Brito and Rieder, 2006; 
Demidenko et al., 2008). Similarly, transient (∼16–20 h) prolongations 
of prometaphase allow completion of mitosis but the daughter cells 
nevertheless arrest (Ciciarello et al., 2001; Tritarelli et al., 2004). For 
such grossly prolonged mitoses, daughter cell arrest can be attrib-
uted to p53 activation following DNA damage starting after ∼16 h in 
prometaphase (Orth et al. [2012] also see Dalton et al. [2007], 
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Quignon et al. [2007], and Hayashi et al. [2012]). This DNA damage 
results from the sublethal activation of the apoptosis pathway during 
prometaphase and consequent caspase-activated DNase activity 
(Orth et al., 2012). For transformed cells held continuously in mitosis 
with microtubule agents such as taxol, robust activation of the apop-
tosis pathway during prometaphase kills them during mitosis if they 
do not slip into interphase too soon (reviewed in Topham and Taylor 
[2013]).
For untransformed human cells, we investigated the relationship 
between prometaphase duration of mother cells and the proliferative 
capacity of daughter cells under standard culture conditions (Uetake 
and Sluder, 2010). Daughter cells proliferated if prometaphase lasted 
<1.5 h. However, when cells spent >1.5 h in prometaphase, the 
daughters remained viable but arrested in G1 despite the normal 
divisions of their mothers. This daughter cell arrest occurred after 
prometaphase durations less than those needed for apoptotic death 
in mitosis for cells constitutively arrested in mitosis (Gascoigne and 
Taylor, 2008; Topham and Taylor, 2013; Sloss et al., 2016). The G1 
arrest we observed was p38 and p53 dependent and enforced by 
p21 expression. The basis for the activation of a p38–p53 response 
after modest prolongation of prometaphase was a mystery, because 
we ruled out DNA damage, a high incidence of lagging chromo-
somes, prolonged activity of the mitotic checkpoint, and p53 accu-
mulation during mitosis for prometaphase durations lasting up to 6 h.
When we prolonged prometaphase for >1.5 h and transiently 
inhibited p38 activity for at least 3 h just after mitosis, the daughter 
cells progressed through interphase and divided again. Remarkably, 
all granddaughter cells arrested in G1, even though they were born 
from mitoses of normal duration (Uetake and Sluder, 2010). Thus, 
after more than ∼1.5 h in prometaphase, there is an irreversible 
change in the properties of the daughter cells that cannot be 
“erased” by progression through interphase and mitosis.
The purpose of the present study is to gain insight into the basis 
for the DNA damage and mitotic defect independent G1 arrest of 
daughter cells after moderate prolongation of prometaphase. We 
investigate what happens during modestly prolonged prometa-
phase that leads to a durable change in the properties of daughter 
cells and the nature of that change.
RESULTS
We used hTERT RPE1 cells, untransformed human cells that show a 
qualitatively identical response to prolonged prometaphase as pri-
mary human fibroblasts (Uetake and Sluder, 2010). We used 0.08 μM 
nocodazole to diminish spindle size and interfere with chromosome 
attachment, thereby prolonging mitotic checkpoint activity. No cells 
slipped out of mitosis during any of the nocodazole treatments. The 
G1 arrest of daughter cells after prolonged prometaphase is not 
nocodazole specific; monastrol, taxol, and MG132 produced quali-
tatively similar results (Uetake and Sluder, 2010).
Death and senescence after prolonged prometaphase
Since grossly prolonged prometaphase leads to the partial activa-
tion of the apoptosis pathway (Orth et al., 2012), we tested whether 
this also holds true for moderate prolongations of prometaphase 
(up to 6 h) that do not lead to DNA damage under standard culture 
conditions (Uetake and Sluder, 2010). We started by following the 
long-term fate of individual daughter cells born of mothers spend-
ing up to 6 h in prometaphase. Asynchronous cultures were treated 
with nocodazole for 4 h and mitotic shake-off cells were kept in no-
codazole for another 2 h. Thus, all cells spent 2–6 h in prometa-
phase, times sufficient to give a G1 arrest of all daughters (Uetake 
and Sluder, 2010). For 136 daughters continuously filmed for 303 h 
(almost 13 d), 69/136 (51%) eventually died (dots above the time 
line, Figure 1A), almost all before the culture became confluent at 
∼240 h (asterisk above time line) due to the proliferation of 1% of the 
cells starting at 72 h (Uetake and Sluder, 2010). This resumption of 
proliferation in a few cells could be due to reversal of the apoptotic 
program (Tang et al., 2012). Figure 1B shows two examples of pro-
nounced blebbing activity followed by cell death. To control for han-
dling and observation conditions we treated asynchronous cells with 
nocodazole for 30 min, shook off mitotic cells, and then continu-
ously followed them after drug washout. All 40 daughters prolifer-
ated, and after the culture became confluent at ∼120 h (asterisk un-
der the time line), only 15/1776 cells (0.8%) present at the end of the 
film runs had died (Figure 1A, dots under the time line).
For daughters of mothers held 2–6 h in prometaphase, 68/109 
cells (62%) showed surface exposure of phosphatidylserine by 18 h 
after nocodazole removal, indicative of early-stage apoptosis as de-
tected with fluorescein isothiocyanate (FITC)-tagged annexin V (re-
viewed in Krysko et al. [2008]) (Figure 1C, all cells). By 96 h all of the 
annexin V–positive cells had propidium iodide positive nuclei indi-
cating surface membrane permeability in later stage apoptosis. For 
daughters still living at 72 h, 228/242 (94%) exhibited β-galactosidase 
staining, indicative of senescence (Figure 1D, first panel, and middle 
panel for 96 h), unlike any of 312 cells in the control culture treated 
for 30 min with nocodazole (Figure 1D, right-hand panel). Together 
these results reveal that prometaphase durations of 6 h or less lead 
to the activation of the apoptosis pathway but not in an immediately 
lethal manner.
MCL-1 activity loss during prolonged prometaphase
We next investigated the basis for the partial activation of the apop-
tosis pathway during prometaphase. The experimental platform 
used is described in Uetake and Sluder (2010) and here under 
Materials and Methods. Briefly, we prolonged prometaphase to 
varying extents in mother cells and followed the proliferative capac-
ity of their daughters. Asynchronous cultures were treated for 6 h 
with 0.08 μM nocodazole to diminish spindle assembly and main-
tain mitotic checkpoint activation. Fields of cells were continuously 
followed so that the times when individual cells entered mitosis 
were known. Those entering mitosis early spent more time in pro-
metaphase than those entering mitosis near the end of the 6-h 
treatment. After drug washout, the same cells were continuously 
followed to determine the proliferative capacity of their daughters. 
By following individual cells, we precisely knew their prometaphase 
durations and the behavior of their daughters. All experiments each 
involved multiple preparations and time-lapse runs conducted on 
separate days.
The consequences of prolonging prometaphase without addi-
tional intervention are shown in Figure 2A. This we call the “basic” 
experiment. Each vertical bar represents a daughter cell and the 
height of the bar indicates the duration of prometaphase for its 
mother cell. Daughters that proliferated are shown as light-colored 
bars and those that arrested in G1 are shown as dark bars. Some 
bars are single because one of the two daughter cells crawled off the 
field of view. The vertical dashed line indicates the prometaphase 
duration of the mother cells (1.5 h) beyond which all daughters arrest 
in G1. Thus, the temporal tolerance of RPE1 cells for prolonged pro-
metaphase is 1.5 h under standard culture conditions. Prometa-
phase in control cells averages 18 min (range 9–30 min, n = 117).
The expression and hence activity levels of the antiapoptotic 
protein MCL-1 gradually decline during prometaphase in cells con-
stitutively held in mitosis with nocodazole or Taxol (Harley et al., 
2010; Wertz et al., 2011; Sloss et al., 2016). We tested whether 
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reduction of MCL-1 activity influences how long mother cells must 
spend in prometaphase before the future daughter cells become 
committed to arrest in G1. We partially diminished MCL-1 activity 
with the specific small molecule inhibitor MIM1 at a concentration 
that did not kill control cells or change their cell-cycle timing. Our 
rationale was that partial diminishment of MCL-1 activity should 
reveal its influence on determining the range of prometaphase 
durations beyond which daughter cells arrested in G1. At 10 μM 
FIGURE 1: (A) Times of individual daughter cell death after prolonged prometaphase. Points above the time line: for 
daughters born of 136 mothers spending 2–6 h in prometaphase, 69/136 (51%) died, and all but one died before the 
preparation became confluent (asterisk) due to the proliferation of a few cells starting at 72 h. Points below the time 
line: for daughters born of 40 mothers treated with nocodazole for 30 min, all daughters proliferated and by the end of 
the film runs 15/1776 (0.8%) of the progeny died, all after the culture became confluent (asterisk). Time line is hours 
after removal of nocodazole. (B) Two examples of the death of daughters born of mothers spending 2–6 h in 
prometaphase. First frames show blebbing activity and the second frames show terminal compaction of the same cells 
(arrows). Times are hh:mm after nocodazole removal. Phase contrast images, bar = 20 μm. (C) For daughters born of 
mothers held 2–6 h in prometaphase, evidence for activation of the apoptotic pathway at 18 h after nocodazole removal 
as detected with FITC-tagged annexin V (green contrast) for surface phosphatidylserine. Of the annexin V–positive cells, 
14/68 (21%) show propidium iodide PI-positive nuclei (red contrast), indicating surface membrane permeability during 
later stage apoptosis (right-hand cell).  Phase contrast/fluorescence image, bar = 20 μm. (D) Senescence in some 
G1-arrested daughter cells born of mothers held 2–6 h in prometaphase. First and second frames show examples 
β-galactosidase positive cells still alive at 72 and 96 h after nocodazole removal. Third frame, none of the daughter cells 
born of mothers treated with nocodazole for 30 min are β-galactosidase positive at 72 h. Phase contrast images, 
bar = 20 μm.
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continuous exposure (IC50 4.8 μM; Cohen et al. [2012]), cells re-
peatedly cycled with normal morphology and timing (average 19 h, 
range 18–23 h, n = 41 vs. average of 20 h, range 16–26 h, n = 40 for 
untreated cells). This equivalency indicates that the drug per se, at 
the concentration used, does not lead to a G1 arrest after normal 
mitosis or have obvious pleiotropic activity.
We applied 10 μM MIM1 and 0.08 μM nocodazole for 6 h and 
then removed both. For prometaphase durations up to 48 min, 
none of the daughters arrested. However, for prometaphase dura-
tions 48–90 min, 24/32 (75%) of the daughters arrested (Figure 2B). 
For the progeny of mother cells that spent >90 min in prometa-
phase, all arrested. These results reveal that reduction in MCL-1 ac-
tivity reduces the temporal tolerance for prolonged prometaphase.
This reduction in the temporal tolerance for prometaphase dura-
tion should not be due to residual MIM1, if any, in the daughter 
cells. First, continuous application of this concentration of MIM1 to 
control cells does not alter the cell cycle or produce a G1 arrest in 
any daughter cells. Second, continuous treatment with MIM1 start-
ing at nocodazole washout does not alter the temporal tolerance for 
prolonged prometaphase. All daughters of mothers spending <1.5 
h in prometaphase proliferated (n = 32) while all those born of moth-
ers spending >1.5 h in prometaphase arrested (n = 21).
To back up our observations with MIM1 we knocked down 
MCL-1 and obtained similar results. Forty-eight hours after small in-
terfering RNA (siRNA) transfection (knockdown efficacy shown in 
Supplemental Figure S1A), asynchronous cultures were treated with 
nocodazole for 6 h. Thirty-three of 74 (45%) daughters arrested 
though their mothers spent <1.5 h in prometaphase (Supplemental 
Figure S1C) a clear departure from the basic experiment (Figure 2A). 
Cells transfected with a control siRNA showed a similar response to 
prolonged prometaphase as untransfected cells (Figure 2A vs. Sup-
plemental Figure S1D). Thus, reduced MCL-1 expression leads to a 
reduced temporal tolerance for prolonged prometaphase.
The gradual loss of MCL-1 during prolonged mitosis involves 
SCFFbw7-mediated degradation in some but not all cell types 
(Inuzuka et al., 2011; Wertz et al., 2011) (reviewed in Millman and 
Pagano [2011] and Sloss et al. [2016]). We next sought to slow the 
loss of MCL-1 during prolonged prometaphase by knocking down 
Fbw7. To test the practical effect of Fbw7 knockdown for prometa-
phase MCL1 levels in our RPE1 cells, asynchronous cultures were 
transfected with Fbw7 siRNA and 48 h later treated with 0.08 μM 
nocodazole for 3 h. Mitotic shake-off cells were then cultured for 
another 3 h in nocodazole so that all cells assayed spent 3–6 h in 
prometaphase. We also ran parallel cultures of untransfected cells 
for comparison. In two experiments, MCL1 levels in Fbw7 knock-
down cells were 3.1 and 3.7 times higher than those of the untrans-
fected cells (Supplemental Figure S1B), consistent with the results of 
Wertz et al. (2011) for the same siRNA sequence (Wei et al., 2005).
We tested the effects of Fbw7 knockdown on the temporal toler-
ance for prolonged prometaphase. Forty-eight hours after siRNA 
transfection, asynchronous cultures were treated with nocodazole 
for 6 h. After drug washout, 15/58 (26%) of the daughters prolifer-
ated though their mothers spent 1.5–4.5 h in prometaphase (Figure 
2C). The observation that not all daughters born of mothers spend-
ing >1.5 h in prometaphase proliferated may be due to cell-to-cell 
variability in Fbw7 knockdown in conjunction with both continued 
MCL1 synthesis during mitosis, balanced against its ubiquitin-inde-
pendent proteolytic degradation (Sloss et al., 2016). Although Fbw7 
knockdown could alter the stability of other proteins, we did not 
observe any morphological or cell-cycle defects in daughter cells 
born of mothers spending <1.5 h in prometaphase. Additionally, 
FBW7 knockdown cells, not treated with nocodazole, repeatedly 
cycled with normal morphology and timing, indicating the lack of 
obvious pleiotropic effects (average 20 h, range 15–23 h, n = 12, vs. 
average of 20 h, range 16–26 h, n = 40, for untreated cells). Together, 
FIGURE 2: (A) Relationship between prometaphase duration and 
daughter cell proliferation under standard culture conditions—the 
“basic” experiment (redrawn from Figure 1B of Uetake and Sluder 
[2010]). Asynchronous cultures were treated with nocodazole for 6 h 
and entry of individual cells into mitosis followed. After drug washout, 
daughters of previously followed mothers were continuously 
followed. Each vertical bar represents a daughter cell remaining in the 
field of view and the height of the bar indicates the prometaphase 
duration for its mother cell. The bars are ordered by the duration of 
prometaphase for the mother cells. Daughters that proliferated are 
shown as light-colored bars, and those that arrested in G1 are shown 
as dark colored bars. The vertical dashed line indicates the 
prometaphase duration of the mother cells (90 min) beyond which all 
daughter cells arrested in G1. (B) Partial inhibition of MCL1 activity 
during prometaphase reduces the temporal tolerance for prolonged 
prometaphase. Asynchronous cultures were treated with nocodazole 
plus MIM1 for 6 h and both drugs washed out. Significantly fewer 
daughters born of mothers spending <1.5 h in prometaphase 
proliferated relative to the basic experiment (A): p = 0.0019. For the 
daughters born of mothers spending >1.5 h in prometaphase, there 
was no significant increase in the proportion of cells that proliferated 
(p = 1.0). (C) Knockdown of the F-box protein FBW7 allows some 
daughter cells to proliferate even though their mothers spent up to 
4.6 h in prometaphase. Forty-eight hours after siRNA transfection, 
asynchronous cultures were treated with nocodazole for 6 h and the 
progeny of individual mother cell were continuously followed. For 
three pairs of daughter cells born of mothers spending >1.5 h in 
prometaphase, one daughter proliferated while its sister arrested. 
Significantly more daughters born of mothers spending >1.5 h in 
prometaphase proliferated relative to the basic experiment (A): 
p = 0.00012. For the daughters born of mothers spending <1.5 h in 
prometaphase, there was no significant decrease in the proportion of 
cells that proliferated (p = 1.0).
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these results indicate that partial stabilization of MCL1 levels pro-
longs the temporal tolerance for prolonged prometaphase.
Other antiapoptotic Bcl-2 family members
Although the expression levels of the antiapoptotic proteins Bcl-xL, 
Bcl-2, and Bcl-w do not change during prometaphase, their activity 
diminishes during prolonged prometaphase due to phosphorylation 
by Cdk1 (Terrano et al. [2010] and references therein).  We next tested 
whether activity loss for these antiapoptotic Bcl family members 
during prolonged prometaphase participates in the G1 arrest of 
daughter cells. We did this because Bcl-xL is reported to be a primary 
negative regulator of apoptosis during mitotic arrest of some cancer 
cells (Shi et al., 2011); its inhibition sensitizes cells to mitotic blockers 
(Bennett et al., 2016); and Bcl-2/Bcl-xL inhibition potentiates apopto-
sis after prolonged mitosis in transformed cells (Colin et al., 2015).
We treated asynchronous cultures with 1 μM ABT-263 (Navito-
clax) plus nocodazole for 6 h and then washed both out.  ABT-263 
inhibits Bcl-xL, Bcl-2, and Bcl-w (IC50s: <0.5 nM, <1 nM, and <1 nM, 
respectively; Vogler et al. [2009]). We found that all 41 daughters 
born of mothers spending <1.5 h in prometaphase proliferated 
(Supplemental Figure S2, top). Thus, inhibition of these other anti-
apoptotic Bcl-2 family members does not additionally predispose 
daughter cells to arrest for prometaphase durations <1.5 h, unlike 
the case for partial MCL-1 inhibition (Figure 2B). Thirty of 67 (45%) 
of the daughters of mothers spending >1.5 h in prometaphase ar-
rested but remained alive (Supplemental Figure S2, top). Another 
three (asterisks) died at times ranging from 63–104 h after no-
codazole removal.  We also observed that 22 mother cells died dur-
ing prometaphase (Supplemental Figure S2, bottom), consistent 
with the report that continuous application of 1 μM ABT-263 pro-
motes cancer cell killing during or just after slippage out of mitosis 
(Shi et al., 2011).  Surprisingly, 31 daughters still in the fields of view 
proliferated even though their mothers spent between 1.75 and 
2.75 h in prometaphase. This is consistent with reports that MCL-1 
can be translated during mitosis (Sloss et al., 2016) and ABT-263 
inhibition of Bcl-xL, Bcl-2, and Bcl-w can lead to increased expres-
sion and activity of MCL-1 (Williams et al., 2017).
Effectors of apoptosis
To further test whether partial activation of the apoptotic pathway 
leads to daughter cell arrest, we tested whether diminishing pro-
apoptotic elements of this pathway increases the temporal tolerance 
of cells for prolonged prometaphase. We treated asynchronous 
cultures with 2.5 μM Bax channel blocker iMAC1 (IC50 520 nM) and 
nocodazole for 6 h and washed out both. Sixteen of 46 (35%) 
daughters proliferated, even though their mothers spent between 
1.5 and 5 h in prometaphase (Figure 3A). The fact that not all daugh-
ters proliferated may reflect cell-to-cell variability in the loss of MCL-
1, Bak activity, and incomplete inhibition of Bax channels.
To back up these observations we knocked down Bak and Bax 
with a mixture of validated siRNA constructs (Supplemental Figure 
S3A) and obtained similar results. Forty-eight hours after siRNA 
transfection, asynchronous cultures were treated with nocodazole 
for 6 h. We found that 9/42 (21%) daughters born from mothers 
spending 2–4 h in prometaphase proliferated. Together these re-
sults indicate that diminishing the apoptotic response increases the 
temporal tolerance for prolonged prometaphase.
To test the involvement of caspase activities in the G1 arrest of 
daughter cells after sufficiently prolonged prometaphase, we par-
tially inhibited caspase activities during and after prolonged pro-
metaphase with cell permeable z-VAD (OMe)-fmk, which is con-
verted to the pan-caspase inhibitor z-VAD-fmk by intracellular 
esterase activity. We treated asynchronous cultures with 20 μM 
z-VAD (OMe)-fmk for 12 h to allow drug entry/cleavage and after 
washout treated with nocodazole for 6 h. After nocodazole removal, 
46/77 (60%) of the daughters remaining in the fields of view prolifer-
ated, even though their mothers spent 1.5–5.5 h in prometaphase 
(Figure 3B). The arrest of other daughters may be due to insufficient 
caspase inhibition in those particular cells. These results point to the 
functional importance of caspase activity in effecting the arrest of 
daughter cells after prolonged prometaphase.
To back up this functional approach, we assayed for the presence 
of activated caspase-3, an effector caspase, during prolonged pro-
metaphase. This caspase is expressed as an inactive procaspase 
that is activated by proteolytic removal of the pro-domain and 
cleavage of the intersubunit linker (Riedl and Shi, 2004). We treated 
asynchronous cultures with nocodazole for 6 h and immediately 
fixed them for immunofluorescence labeling with a monoclonal an-
tibody that recognizes only the large fragment of cleaved/activated 
caspase-3, not full-length caspase-3 (Supplemental Figure S3C). For 
comparison, we did the same for parallel cultures treated for 30 min 
with nocodazole. We then measured the fluorescence intensity in 
FIGURE 3: (A) Application of the Bax channel blocker iMAC1 just 
during prolonged prometaphase allows some daughter cells to 
proliferate even though their mothers spent between 1.5 and 5 h in 
prometaphase. Asynchronous cultures were treated with nocodazole 
plus 2.5 μM iMAC1 for 6 h and both drugs washed out. For two pairs 
of daughter cells born of mothers spending >1.5 h in prometaphase, 
one daughter proliferated while its sister arrested. Significantly more 
daughters born of mothers spending >1.5 h in prometaphase 
proliferated relative to the basic experiment (Figure 2A): p = 3.1 × 10–6. 
For the daughters born of mothers spending <1.5 h in prometaphase, 
there was no significant decrease in the proportion of cells that 
proliferated (p = 1.0). (B) Pancaspase inhibitor allows some daughter 
cells to proliferate even though their mothers spent between 1.5 and 
5.5 h in prometaphase. Asynchronous cultures were treated with 20 
μM z-VAD (OMe)-fmk for 12 h to allow drug entry/cleavage. After this 
agent was washed out, the cultures were treated with nocodazole for 
6 h and daughter cells were continuously followed. Significantly more 
daughters born of mothers spending >1.5 h in prometaphase 
proliferated relative to the basic experiment (Figure 2A): p = 3.2 × 10–12. 
For the daughters born of mothers spending <1.5 h in prometaphase, 
there was no significant decrease in the proportion of cells that 
proliferated (p = 1.0).
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individual mitotic cells in both populations. The distributions of indi-
vidual mitotic cell gray-scale values for the two populations are 
shown in Supplemental Figure S3B. The mean values for the two 
populations are significantly different (p < 0.00001). These results 
reveal the presence of activated caspase-3 in mitotic cells and an 
increase in its levels during prolonged prometaphase.
Oxidative stress during prolonged prometaphase
Since oxidative stress can trigger apoptosis (reviewed in Wu et al. 
[2015] and Hampton and O’Connor [2016]) and lead to MCL-1 inac-
tivation (Inoshita et al., 2002), we tested whether oxidative stress 
participates during prolonged prometaphase in arresting daughter 
cells. We did this because oxygen levels under standard culture con-
ditions (∼20% or a pO2 of 140 mm Hg at sea level) is higher than 
physiological conditions. In vivo mammalian levels range from 3% 
to 14% depending on the tissue (Sen and Roy, 2010).
To increase oxidative stress, asynchronous cultures were ex-
posed to nocodazole and the oxidant KBrO3 (1 mM) for 6 h and 
both washed out. Twenty-one of 30 (70%) of the daughters born of 
mothers spending <1.5 h in prometaphase arrested as did all daugh-
ters born of longer prometaphase durations; none later died (Figure 
4A). This is not due to persistent oxidative damage because same 
preparation cells that were in interphase during the nocodazole/oxi-
dant treatment cycled after KBrO3 removal with the same timing 
(average 20.5 h, range 14–29 h, n = 11) as cells of separate control 
cultures (average 21 h, range 15–28 h, n = 20). Thus, increased oxi-
dative stress reduced prometaphase durations that lead to daugh-
ter cell arrest.
We next used two means to determine whether reduced oxida-
tive stress during mitosis would increase a cell’s tolerance for 
prolonged prometaphase. First, we used external application of 
reduced glutathione, a tripeptide antioxidant normally present at 
0.5–10 mM inside cells (Franco and Cidlowski, 2009). Asynchronous 
cultures were exposed to nocodazole and 50 μM reduced glutathi-
one for 6 h and both washed out. We observed the proliferation of 
25/71 (35%) of the daughters born of mothers spending >1.5 h in 
prometaphase (Supplemental Figure S4A), a significant difference 
from the basic experiment (Figure 2A). Generally, cells do not import 
glutathione, but uptake has been reported in primary cultures of hu-
man RPE cells (Kannan et al., 2001). In contrast, external application 
of 50 μM oxidized glutathione did not promote the proliferation of 
daughters born of prometaphase durations >1.5 h (Supplemental 
Figure S4B). These results indicate that reduced oxidative stress can 
increase the temporal tolerance for prolonged prometaphase.
To further test whether reduced oxidative stress can influence 
the temporal tolerance for prolonged prometaphase, we worked 
with cells held at reduced oxygen levels. For control cells cultured at 
3% oxygen, cell-cycle timing was normal (mitosis average 35 min. 
range 19–48 min, n = 20, and interphase 21 h, range 15–28 h, n = 
20, values closely similar to those observed at atmospheric oxygen 
levels—mitosis average 35-min range, 18–57 min, n = 20, and inter-
phase 20-h range, 16–26 h, n = 20).
Asynchronous cultures were treated with nocodazole for 10 h in 
medium equilibrated with 3% oxygen and then followed under at-
mospheric oxygen levels after drug washout. For daughters born of 
mothers spending 1.5–6.2 h in prometaphase, 14/35 (40%) prolifer-
ated while none proliferated for longer prometaphase durations 
(Figure 4B).
The arrest of daughter cells at low oxygen levels can occur with-
out DNA damage. Even though 6-h prometaphase durations do not 
lead to DNA damage in our RPE1 cells (Uetake and Sluder, 2010), we 
tested for DNA damage in cells spending 6–10 h in prometaphase. 
Immunofluorescence localization for H2AX foci in individual daugh-
ter cells previously followed in vivo revealed that 24/50 (48%) of the 
daughter cells born of mothers spending 6.8–10.7 h in prometa-
phase showed low levels of DNA damage that should contribute to 
their arrest (Supplemental Figure S4C). However, the other 26/50 
(52%) of this group showed no DNA damage, yet they arrested. 
Together, these results indicate that reduced oxygen levels can in-
crease the temporal tolerance for prolonged prometaphase up to 
∼6 h for some cells but does not prevent the arrest of cells held lon-
ger in prometaphase, even those that do not show DNA damage.
In separate experiments with up to 6-h prometaphase durations, 
we found that reduction of MCL1 activity at 3% oxygen shortened 
the temporal tolerance for prolonged prometaphase. As a baseline, 
we treated asynchronous cultures with nocodazole for 6 h at 3% oxy-
gen and then followed daughter cells under atmospheric oxygen 
levels after drug removal. Consistent with the previous experiment, 
34/52 (65%) of the daughter cells born of mothers held 1.5–6 h in 
prometaphase proliferated (Figure 5A). When the same experiment 
was conducted with 10 μM MIM1 present just during the nocodazole 
treatment, all daughters of mothers spending >1.5 h in prometa-
phase arrested (Figure 5B). For mother cells that spent 1.2–1.5 h in 
prometaphase, 9/11 (82%) of the daughters arrested. Together 
FIGURE 4: (A) Increased oxidative stress just during prometaphase 
reduces the temporal tolerance for prolonged prometaphase. 
Asynchronous cultures were treated with nocodazole plus KBrO3 for 
6 h and then both were washed out. Significantly fewer daughters 
born of mothers spending <1.5 h in prometaphase proliferated 
relative to the basic experiment (Figure 2A): p = 4.8 × 10–5. For the 
daughters born of mothers spending >1.5 h in prometaphase, there 
was no significant increase in the proportion of cells that proliferated 
(p = 1.0). (B) Reduced oxygen level increases the temporal tolerance 
for prolonged prometaphase up to 6 h but does not abrogate the G1 
arrest of daughter cells born of longer prometaphase durations. 
Asynchronous populations were treated with nocodazole for 10 h in 
medium equilibrated with 3% oxygen. After nocodazole washout, the 
daughter cells were followed at ambient oxygen levels.
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these results support the importance of MCL-1 activity loss in trig-
gering a G1 arrest of daughter cells at physiological oxygen levels.
Post–mitotic activation of p38
The G1 arrest of daughters after prolonged prometaphase requires 
p38 activity after the mother cells complete mitosis. Inhibition of p38 
activity just during prolonged prometaphase does not abrogate the 
G1 arrest of daughters while its continuous inhibition after no-
codazole washout allows all daughters to proliferate regardless of 
the prometaphase duration for their mothers (Uetake and Sluder, 
2010). To gain insight into these observations we determined when 
p38 is activated. We treated asynchronous cultures with nocodazole 
for 4 h and cultured shake-off mitotic cells for another 2 h in no-
codazole. After drug removal, aliquots of shake-off cells were 
processed for western blotting at 0 min (prometaphase), 40 min 
(anaphase/telophase), 1.5 h (early G1), and 5 h (mid to late G1). 
Shake-off cells from control populations showed activating phos-
phorylations on Thr180 and Tyr182 of p38 (Figure 6, first lane), as 
previously reported for cells early in mitosis (Takenaka et al., 1998; 
Campos et al., 2002; Fan et al., 2005; Tang et al., 2008; Lee et al., 
2010). In contrast, after 2–6 h in prometaphase, activating phosphor-
ylation levels in mitosis were low (0 min lane) and remained so 
through the end of mitosis (40 min lane). In early G1, activating 
phosphorylation levels markedly increased (1.5 h lane) and were low 
again by 5 h after drug removal (5 h lane). Such transient p38 activa-
tion is consistent with the report that continuous exposure to aniso-
mycin leads to a ∼1-h activation of p38 (Lu et al., 2007). These results 
reveal that p38 activation occurs downstream of prolonged mitosis.
FIGURE 5: (A) Reduced oxygen increases the temporal tolerance for 
prometaphase prolonged up to 6 h. Asynchronous populations were 
treated with nocodazole for 6 h in medium equilibrated with 3% 
oxygen. After nocodazole removal, the daughter cells were followed 
at ambient oxygen levels. Significantly more daughters born of 
mothers spending >1.5 h in prometaphase proliferated relative to the 
basic experiment (Figure 2A): p = 1.5 × 10–14. For the daughters born 
of mothers spending <1.5 h in prometaphase, there was no significant 
decrease in the proportion of cells that proliferated (p = 1.0). (B) In 
contrast, partial inhibition of MCL1 activity at reduced oxygen level 
diminishes the temporal tolerance for prolonged prometaphase. Cells 
were treated with MIM1 plus nocodazole at ∼3% oxygen for 6 h, and 
after washout of both drugs, daughter cells were continuously 
followed at ambient oxygen levels.
P38 activation after caspase inhibition
In this study, we earlier provided functional evidence that caspase 
activity participates in the G1 arrest of daughter cells after pro-
longed prometaphase. Given that p38 activity is required for 
daughter cell arrest after prolonged prometaphase, we tested 
whether caspase inhibition would influence the levels of activated 
p38 after prolonged mitosis. In three experiments, we treated asyn-
chronous cultures with 20 μM z-VAD (OMe)-fmk for 12 h to allow 
drug entry/cleavage. After inhibitor washout, the cells were treated 
with nocodazole for 4 h, and mitotic shake-off cells were kept in 
nocodazole for another 2 h.  One and a half hours after nocodazole 
washout, the daughter cells were processed for Western blotting to 
quantify phospho-p38 levels. As a control, asynchronous cultures 
were treated same way with nocodazole but without 20 μM z-VAD 
(OMe)-fmk pretreatment. For cultures treated with the caspase in-
hibitor, the levels of activated p38 were 42%, 64%, and 48% those 
of the parallel control cultures (example shown in Supplemental 
Figure S3D). These results reveal that caspase activity participates 
in the post–mitotic activation of p38. The fact that the levels of ac-
tivated p38 were not zero in the caspase-inhibited cultures may be 
due to incomplete caspase inhibition in some cells, especially after 
the stress inherent in the shake off of their mothers.
Persistence of caspase activity
We previously found that when we prolonged prometaphase for 
>1.5 h and transiently inhibited p38 activity for at least 3 h just after 
mitosis to allow the daughters to get through G1, they progressed 
through interphase and divided again. Remarkably, all granddaugh-
ters arrested in G1, even though they were born from mitoses of 
normal duration (Uetake and Sluder, 2010). Thus, prolonged pro-
metaphase can lead to an irreversible change in the properties of 
the daughter cells that cannot be “erased” by progression through 
interphase and normal mitosis.
To test whether persistent caspase activity participates in the 
granddaughter cell arrest, we first repeated the experiment. 
We treated asynchronous cultures with nocodazole for 6 h and, just 
after its removal, treated with the p38 inhibitor SB 203580 (10 μM) 
FIGURE 6: Transient post–mitotic activation of p38 in daughter cells 
born of mothers that spent 2–6 h in prometaphase. Western blots for 
activated p38, top row (phospho Thr180/Tyr182), and total p38, 
bottom row. First lane: mitotic shake-off cells from control culture. 
0 min–5 h lanes: asynchronous cultures were treated with nocodazole 
for 4 h; mitotic cells were shaken off and cultured another 2 h in 
nocodazole before drug removal. Populations were prepared for 
blotting at the indicated times after nocodazole removal. 0 min lane: 
prometaphase cells collected just after drug removal. 40 min lane: late 
anaphase/telophase cells harvested 40 min after nocodazole removal. 
1.5 h lane: G1 cells collected 1.5 h after nocodazole removal. 5 h lane: 
G1 cells harvested 5 h after nocodazole removal (from a different 
blot). The blots shown are representative of five experiments that 
showed identical results.
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for 8 h and then washed it out. All daughter cells born of mothers 
spending >1.5 h in prometaphase progressed through interphase 
and divided again. All granddaughters arrested, confirming our 
FIGURE 7: Persistent caspase activity leads to granddaughter cell arrest. (A) Asynchronous 
cultures were treated with nocodazole for 6 h and immediately after drug washout treated with 
the p38 inhibitor SB 203580 for 8 h. All daughters born of mothers spending >1.5 h in 
prometaphase progressed through interphase and divided again. However, all granddaughters 
still in the fields of view arrested. For the same preparation daughters born of mothers spending 
<1.5 h in prometaphase all granddaughters proliferated (not diagrammed). (B) The same 
experiment except that the pan-caspase inhibitor z-VAD(Ome)-fmk was included during the 8 h 
SB 203580 treatment. All daughter cells born of mothers spending >1.5 h in prometaphase 
progressed through interphase and divided again, and 87% of the granddaughters proliferated. 
(C) For the same preparation, daughters born of mothers spending <1.5 h in prometaphase all 
granddaughters proliferated.
previous report (Uetake and Sluder 2010) 
(Figure 7A). We then did the same experi-
ment but this time included the pan-caspase 
inhibitor z-VAD(Ome)-fmk (20 μM) along 
with the SB 203580 for 8 h. For mothers 
spending >1.5 h in prometaphase 100/115 
(87%) of their granddaughters proliferated 
(Figure 7B). For the same preparation moth-
ers spending <1.5 h in prometaphase, all 60 
granddaughters proliferated (Figure 7C). 
These results provide functional evidence 
that sufficiently prolonged prometaphase in 
the mother cell leads to persistent caspase 
activity that later participates in grand-
daughter arrest.
DISCUSSION
Response to prolonged prometaphase
Moderate prolongation of prometaphase 
leads to the activation of the apoptosis 
pathway in the absence of DNA damage 
but not in an immediately lethal manner. 
This apoptotic response is slow for half of 
the daughter cells in which it runs to com-
pletion (death 33–288 h after mother cell 
mitosis), and for the other half it leads to se-
nescence. Cells can commit to either apop-
totic death or senescence—with apoptosis 
favored by stronger stresses (Childs et al., 
2014). Our observations are consistent with 
the report of sublethal activation of the 
apoptosis pathway during greatly pro-
longed prometaphase (Orth et al., 2012) 
and the finding that cells can show a graded 
apoptotic response in which a small fraction 
of the mitochondria execute MOMP leading 
to sublethal levels of caspase activity (Ichim 
et al., 2015).
Activation of the apoptotic pathway 
and daughter cell arrest involve the pro-
gressive loss of MCL-1 activity during pro-
metaphase acting in concert with oxida-
tive stress, which can promote MCL-1 
inactivation (Inoshita et al., 2002). Over 
time, these tip the balance of pro- and 
anti-apoptotic activities toward a conse-
quential, albeit partial, apoptotic re-
sponse. Though oxidative stress can par-
ticipate, it is not needed. At 3% oxygen 
levels the temporal tolerance for pro-
longed prometaphase is increased up to 6 
h for many cells but all daughters arrest 
after longer prometaphase durations. At 
such lowered oxygen levels, the extent of 
MCL-1 activity loss is still important, be-
cause when we diminish its activity during 
prometaphase, the temporal tolerance for 
prolonged prometaphase is reduced from 
6 to ∼1.2 h.
For cells in the living mammal, those exposed to atmospheric 
oxygen, such as those of a healing surface wound, ∼90 min in 
prometaphase may be the tipping point for a block to daughter 
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cell proliferation. For cells inside the body that experience ∼3% 
oxygen levels the tolerance for prometaphase duration would be 
∼6 h. Cells of tissues, such as those in lung alveoli and the pulmo-
nary aorta, which normally experience up to 14% oxygen, may 
have an intermediate tolerance for prolonged prometaphase.
Although the expression levels of the antiapoptotic proteins Bcl-
xL, Bcl-2, and Bcl-w do not change during prometaphase, their 
activity diminishes due to phosphorylation by Cdk1 (Terrano et al., 
2010).  Unlike partial MCL-1 inhibition, diminishment of their activi-
ties did not promote the arrest of daughters born of mothers spend-
ing <1.5 h in prometaphase. Thus, for RPE1 cells MCL1 activity loss 
during prolonged prometaphase more directly promotes daughter 
cell arrest than activity loss for these other antiapoptotic Bcl-2 family 
members.
In our initial study (Uetake and Sluder, 2010), we prolonged pro-
metaphase with the proteasome inhibitor MG132 at atmospheric 
oxygen levels and found that all daughter cells arrested if born of 
mothers spending >1.5 h in prometaphase. This seems paradoxical 
because MG132, while present, should protect MCL-1 from proteo-
lytic degradation, thereby allowing daughter cell proliferation 
regardless of prometaphase duration. An explanation for this daugh-
ter cell arrest is that mother cells spending longer in prometaphase 
suffer more accumulated oxidative stress. MG132 is said to induce 
apoptosis through the formation of reactive oxygen species (Wu 
et al., 2002; Han and Park, 2010; Guo and Peng, 2013). Also, Inoshita 
et al. (2002) report that oxidative stress induces c-Jun N-terminal 
kinase (JNK) activation that leads to the phosphorylation and inacti-
vation of MCL-1. This in turn would promote daughter cell arrest 
despite inhibition of the proteolytic loss of MCL-1.
When prometaphase is prolonged with nocodazole or monastrol 
at atmospheric oxygen levels, there is a sharp break between pro-
metaphase durations that do and do not allow daughter cell prolif-
eration (Uetake and Sluder, 2010). For all other experimental condi-
tions, there is a range of prometaphase durations over which some 
daughters arrest and some proliferate. During prolonged prometa-
phase, should there be any cell-to-cell variation in the changing bal-
ance of pro- and anti- apoptotic activities when cells are at the cusp 
of activating a consequential apoptotic response (see Flusberg and 
Sorger [2015]), the lack of a sharp break between daughter cell pro-
liferation and arrest is not surprising. Under less than extreme cir-
cumstances apoptosis is not a digital live or die phenomenon; it can 
be partial (Orth et al., 2012; Ichim et al., 2015) and even be revers-
ible (Tang et al., 2012). This may explain why partially stabilizing 
MCL-1 levels or partially inhibiting proapoptotic factors such as BAX 
or caspases allows some but not all of the daughters to proliferate 
after their mothers spent >1.5 h in prometaphase. In this regard, we 
noted in some experiments a few cases in which one daughter ar-
rested while its sister proliferated after prolonged prometaphase. 
Since Mcl-1 activity participates in the intrinsic (mitochondrion 
based) apoptotic pathway, this phenomenon could be due to un-
equal inheritance of the small percentage of mitochondria undergo-
ing MOMP in response to sublethal stress (Ichim et al., 2015).
The p53 stabilizing activities of 53BP1 and USP28 are required 
for daughter cell arrest downstream from prolonged prometaphase 
(Fong et al., 2016; Lambrus et al., 2016; Meitinger et al., 2016). How 
the p53-53BP1-USP28 complex is assembled and initiates p53 sta-
bilization after prolonged mitosis, in the absence of DNA damage, 
is an intriguing issue that has yet to be investigated (reviewed in 
Lambrus and Holland [2017]). P53 stabilization does not appear to 
be due to activity of this complex during prometaphase, because 
we did not find an increase in p53 levels for cells held in prometa-
phase for almost 4 h (Uetake and Sluder, 2010). Moreover, at low 
oxygen levels, prometaphase durations up to 6 h allowed many 
daughter cells proliferate, suggesting no significant prometaphase 
accumulation of p53.
The prometaphase loss of 53BP1 from kinetochores (in ∼88% of 
the cells by 60 min into mitosis) raised the issue that this delocaliza-
tion could be how cells sense prometaphase duration and trigger a 
block of daughter cell proliferation (Fong et al., 2016). However, un-
der low-oxygen conditions we find that prometaphase durations up 
to 6 h allow many daughter cells to proliferate. Thus, daughter cells 
can proliferate when born from mitoses in which 53BP1 should be 
gone from all kinetochores well before anaphase.
For cells synchronized in G2 and then released into mitosis, 
prolonging prometaphase with the Eg5 inhibitor monastrol can 
lead to centrosome fragmentation and mother–daughter centriole 
separation (Karki et al., 2017). We also observed centrosome ex-
pansion during prolonged prometaphase in the presence of mon-
astrol. However, we did not observe centriole separation or spin-
dle multipolarity when prometaphase was prolonged up to 6 h 
with nocodazole.
Apoptosis and daughter cell arrest
An important question is how activation of the apoptosis pathway 
during prolonged prometaphase leads to the G1 arrest of the 
daughter cells. This arrest is dependent on p38 activity after mitosis 
and the subsequent activity of the p53 (Uetake and Sluder, 2010; 
Fong et al., 2016; Lambrus et al., 2016; Meitinger et al., 2016). Since 
p38 activates p53 (Cuenda and Rousseau, 2007), the question is 
how the apoptotic response during prometaphase activates p38. 
This occurs by caspase cleavage of MEKK-1, which produces a ki-
nase active C-terminal fragment that activates MKK3 and MKK6 that 
in turn phosphorylate the p38 proteins at activating sites (Cardone 
et al., 1997; Nakagami et al., 2001; Zarubin and Han, 2005; Cuenda 
and Rousseau, 2007). P38 activates p53 after mitosis and 53BP1/
USP28 activities stabilize p53 to allow its accumulation (Fong et al., 
2016; Lambrus et al., 2016; Meitinger et al., 2016). P53 activation 
leads to p21 expression that arrests the cell cycle in G1.
Activation of p38 downstream of the apoptotic pathway 
(Nakagami et al., 2001) is supported by our finding that p38 does 
not show activating phosphorylations at the end of prolonged 
prometaphase; rather it is transiently phosphorylated ∼1.5 h after 
nocodazole removal. Also, inhibition of p38 activity just during pro-
longed prometaphase does not abrogate the G1 arrest of daughter 
cells while its continuous inhibition after prolonged mitosis allows all 
daughters to proliferate regardless of prometaphase duration for 
their mothers (Uetake and Sluder, 2010).
The importance of caspase activity for the G1 arrest of daughter 
cells after prolonged prometaphase is evident from our finding that 
caspase inhibition during and after prolonged prometaphase allows 
over half of the daughters to proliferate even though their mothers 
spent between 1.5 and 5.5 h in prometaphase. This is in contrast to 
no daughter cell proliferation in the absence of caspase inhibition 
after >1.5 h prometaphase for the mothers. We also found that cas-
pase inhibition reduced the levels of p38 activation after prolonged 
prometaphase.
For the daughters of mother cells that spent >1.5 h in prometa-
phase, transient inhibition of p38 activity just after mother-cell mito-
sis allows them to progress through interphase and a subsequent 
mitosis of normal duration. Remarkably, all granddaughters arrest 
suggesting an irreversible change in the properties of the progeny 
of such mother cells (Uetake and Sluder [2010] and present study). 
Here we provide functional evidence that this change involves 
persistent caspase activity in the daughter cells. When we inhibited 
Volume 29 November 1, 2018 Prolonged prometaphase and apoptosis | 2641 
caspase activity starting at the transient block to p38 activity after 
prolonged mitosis of the mother, the great majority of the grand-
daughters proliferated without additional inhibition of p38.
Backing up the mitotic checkpoint
The human cell appears to have layers of protection against mitotic 
defects that can lead to genomic instability and the consequent risk 
of transformation. The mitotic checkpoint will hold cells in mitosis 
for hours until defects in bipolar chromosome attachment are re-
solved. If prometaphase is grossly prolonged, the sustained activa-
tion of the apoptotic pathway leads to DNA damage and its conse-
quent p53 response that prevents daughter-cell proliferation. 
However, environmental perturbations can lead to unresolved mi-
totic defects that prolong prometaphase but eventually allow for 
mitotic checkpoint satisfaction and completion of an error prone 
mitosis (Brito et al., 2008). In real life, such defects could arise from 
environmental toxins, heat, radiation, or oxidative stress in tissues 
that experience higher oxygen levels. Our present results reveal that 
partial activation of the apoptotic pathway protects the cell from 
mitotic defects that modestly prolong prometaphase yet allow the 
satisfaction of the mitotic checkpoint before DNA damage occurs.
MATERIALS AND METHODS
Cell culture and reagents
hTERT-RPE1 cells were cultured as described previously (Uetake 
and Sluder, 2004). Nocodazole (#M1404), l-glutathione reduced 
(#G4251), l-glutathione oxidized (#G4376), and KBrO3 (#309087) 
were purchased from Sigma-Aldrich. MCL-1 inhibitor MIM1 
(#444130), Bax channel blocker (iMAC1, #196805), SB 203580 
(#559389), and pan-caspase inhibitor (z-VAD(OMe)-fmk, #627609) 
were purchased from EMD Millipore. ABT-263 (Navitoclax) was 
purchased from ApexBio. Annexin V-FITC early apoptosis detec-
tion kit (#6592) was purchased from Cell Signaling and used ac-
cording to the manufacturer’s instructions. Senescence-specific β-
galactosidase staining was performed according to Dimri et al. 
(1995) with reagents purchased from Sigma-Aldrich. Anti-p38 
(#9218), anti-phospho-p38 (#9211; Thr180/Tyr182), anti-MCL-1 
(#4572), anti-cleaved caspase-3 (#9664; Asp175), and anti-α-
tubulin (#3873) antibodies were obtained from Cell Signaling. 
Western blotting was performed as described previously (Uetake 
and Sluder, 2010). Cells stained for β-galactosidase were observed 
with phase contrast optics and color images recorded with a 
Canon Rebel XS DSLR camera and EOS Utility software (Canon). 
The images were processed with Adobe Photoshop to enhance 
the blue color of the β-galactosidase reaction product; all images 
were processed identically and full frame.  Immunostaining of 
cleaved caspase-3 was performed according to the protocol pro-
vided by the manufacturer. The cells were observed on a Leica 
DMI 6000B using a 20×/0.40 objective, and images were taken 
with a Leica DFC365 FX camera. Fluorescence intensity of Alexa 
fluor 488 was measured using Leica Rebel XS software.
RNA interference
Certified siRNAs against MCL-1(SignalSilence Mcl-1 siRNA I, #6315), 
Bak (SignalSilence Bak siRNA I, #6486), and Bax (SignalSilence Bax 
siRNA I, #6321) were purchased from Cell Signaling. All Signal-
Silence siRNA products from Cell Signaling Technology were tested 
by the manufacturer and shown by the company’s Western blot 
analysis to efficiently knock down the target proteins. Annealed 
siRNA against FBW7 (same sequence as in Wertz et al. [2011] and 
Wei et al. [2005]), and control siRNA (siGENOME Non-targeting 
siRNA#1) were obtained from GE Dharmacon. All siRNAs were di-
luted to 20 μM with nuclease-free water as a stock solution. Two 
microliters of stock solution was mixed with 5 μl of Lipofectamine 
(Invitrogen) and then introduced onto the cells for 2 h; the cells were 
then washed with culture medium and cultured for 48 h (Uetake and 
Sluder, 2010).
Prolonging prometaphase
Asynchronous cultures were mounted in observation chambers 
(Uetake and Sluder, 2012) for 6 h in the presence of 0.08 μM 
nocodazole. Fields were marked with a diamond scribe and continu-
ously followed by video time-lapse microscopy to record when indi-
viduals entered mitosis. Cells entering mitosis assembled short 
bipolar spindles or monopolar spindles, both with monooriented 
chromosomes that prevented mitotic checkpoint satisfaction. None 
slipped into interphase in 6 h. Cells entering mitosis early spent 
several hours in prometaphase before drug washout while cells en-
tering mitosis shortly before drug removal spent little extra time in 
prometaphase. After 6 h, the bottom of the observation chamber 
was removed, the drug washed out with fresh medium several 
times, and the chamber reassembled with fresh medium for further 
observation of the same fields for up to 100 h. In this way, we knew 
precisely the prometaphase duration for each mother cell—here de-
fined as mitosis entry to anaphase onset—and the fate of her 
daughters. All experiments involved multiple preparations and 
time-lapse runs conducted on separate days. During the film runs, 
the medium was changed every 2 d. Live-cell imaging was con-
ducted with Leica DMRXE microscopes equipped with phase-con-
trast optics (10×, 0.3 NA objectives). Images were taken with Orca 
ER, Orca 100 (Hamamatsu), and RetigaEXi (QImaging Corp.) cam-
eras, acquired with HCImage software (Hamamatsu), and exported 
as AVI movies.
Reduced oxygen levels
Culture medium was equilibrated with an atmosphere of 3% oxy-
gen, 5% CO2, 92% nitrogen overnight in a sealed enclosure (Modu-
lar Incubator Chamber from Billups-Rothenberg) in the incubator. 
Observation chambers were filled with the equilibrated media and 
then sealed with a cell bearing coverslip within 30 s under atmo-
spheric conditions. At the end of 6 or 10 h, depending on the ex-
periment, the drugs were washed out with medium that was equili-
brated with atmospheric oxygen level.
Statistical analysis
Statistical tests were performed using “R” Core Team (RC Team, 
2016). The significance of differences in the proliferative capacity of 
daughter cells between the basic experiment (Figure 2A) and other 
experimental conditions (Figures 2, B and C, 3, A and B, 4A, and 5A 
and Supplemental Figures S1, C and D, S3A, and S4, A and B) was 
assessed using pairwise Fisher’s exact tests on the 2 × 2 contingency 
tables of counts of proliferating versus nonproliferating daughter 
cells, separately in two bins based on prometaphase duration: a 
one-tailed test in the “≤90 min” bin was used to test for a decreased 
proportion of proliferating cells compared with the basic experi-
ment (in which 52 of 57 daughter cells were proliferating), and a 
one-tailed test in the “>90 min” bin was used to test for an in-
creased proportion of proliferating cells compared with the basic 
experiment (in which 0 of 54 daughter cells were proliferating). Even 
within these bins, if the probability of nonproliferation increases as 
the prometaphase duration increases, then differences in the distri-
butions of durations between conditions can bias these statistical 
tests. Thus, we also performed analogous Fisher’s exact tests on 
subsets of cells selected to counter this bias, as detailed below; 
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all differences that were significant at p < 0.01 remained so when 
using the more conservative tests, and it is these more conservative 
p values.
Because requiring distributions of durations to be nearly the 
same between conditions can result in many cells being excluded, 
we allowed the distributions to differ, but only in a direction that 
biases the one-tailed tests to be more conservative. For the 
“≤90 minute” bin, in which we tested for a decreased proportion of 
proliferating cells compared with the basic experiment, we allowed 
the distribution to be skewed toward shorter durations than for the 
basic experiment. In this case, we used the Hungarian method 
(function solve_LSAP in the R package clue; Hornik [2005]) to find a 
maximum-sized pairing of cells between experiments subject to the 
constraint that each cell in the basic experiment can only be paired 
with a cell having shorter-or-equal prometaphase duration. Viewing 
the pairing as a matching in a bipartite graph with cells as vertices, 
we assigned weight 0 to illegal edges (those that violate the con-
straint) and weight 1 + αe–|δ| to other edges, where δ is the difference 
in prometaphase durations (which gives a preference to pairings 
between cells with more-similar durations) and α = 1/(N + 1), where 
N is the lesser of the cell counts for the two experiments being com-
pared; this α is small enough to ensure that the maximum-weight 
matching also has the maximum cardinality of legal edges, so that 
as few cells as possible are excluded. The maximum-weight match-
ing need not be unique, so to avoid bias the algorithm was run 
without regard to proliferation status and with cell order random-
ized. For the “>90 minute” bin, in which we tested for an increased 
proportion of proliferating cells compared with the basic experi-
ment, we allowed the distribution to be skewed toward longer dura-
tions than for the basic experiment, using an analogous procedure.
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